Source link : https://www.newshealth.biz/health-news/serum-metabolome-identifies-cancer-in-rheumatic-disease/
TOPLINE: A diagnostic model based on the concentrations of four metabolites and one lipid ratio can reliably predict cancer in patients with rheumatic and musculoskeletal diseases (RMDs) or paraneoplasia, providing high sensitivity and specificity. METHODOLOGY: The metabolome profile can differentiate between nonspecific inflammatory symptoms such as those associated with paraneoplastic conditions or RMDs, which can […]
Author : News Health
Publish date : 2024-05-10 12:42:56
Copyright for syndicated content belongs to the linked Source.